Atlas Trials

Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma

Clinical trial NCT03896113 · UNKNOWN

Trial details

NCT number
NCT03896113
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrium Cancer
Start date
2019-11-13
Primary completion
2022-06-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.